KORU Medical Systems, Inc.
KRMD
$3.83
-$0.07-1.80%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 22.10% | 23.27% | 27.17% | 20.93% | 17.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.10% | 23.27% | 27.17% | 20.93% | 17.53% |
| Cost of Revenue | 26.32% | 24.49% | 38.20% | 26.05% | 15.97% |
| Gross Profit | 19.60% | 22.55% | 20.80% | 18.18% | 18.48% |
| SG&A Expenses | 10.45% | 3.67% | 16.91% | 1.21% | 11.23% |
| Depreciation & Amortization | -9.15% | -15.27% | -10.23% | -3.85% | -6.05% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.08% | 9.73% | 14.03% | 9.20% | 7.10% |
| Operating Income | 30.53% | 65.58% | 49.06% | 73.77% | 36.52% |
| Income Before Tax | 30.79% | 69.06% | 50.78% | 80.83% | 39.76% |
| Income Tax Expenses | -- | 62.07% | -- | -- | -- |
| Earnings from Continuing Operations | 30.79% | 68.81% | 50.78% | 79.07% | 39.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.79% | 68.81% | 50.78% | 79.07% | 39.76% |
| EBIT | 30.53% | 65.58% | 49.06% | 73.77% | 36.52% |
| EBITDA | 35.05% | 67.48% | 55.05% | 89.41% | 40.60% |
| EPS Basic | 31.50% | 69.21% | 51.30% | 79.17% | 40.09% |
| Normalized Basic EPS | 31.45% | 69.34% | 51.16% | 80.74% | 40.00% |
| EPS Diluted | 31.50% | 60.70% | 51.30% | 79.17% | 40.09% |
| Normalized Diluted EPS | 31.45% | 69.34% | 51.16% | 80.74% | 40.00% |
| Average Basic Shares Outstanding | 0.83% | 1.07% | 0.85% | 0.83% | 0.59% |
| Average Diluted Shares Outstanding | 0.83% | 1.07% | 0.85% | 0.83% | 0.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |